ORNBVOrion Oyj
71.95EUR+2.79%Mkt Cap: 11.02B $P/E: 19.14

Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally. It offers pharm…

Indicators:|

Key Statistics

Company
Market Cap11.02B $
Enterprise Value11.16B $
Revenue (TTM)2.12B $
Gross Profit1.32B $
Net Income (TTM)543.80M $
Revenue/Share15.08 USD
Last Price71.95 EUR
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees4.1K
CountryFI
SectorHealthcare
IndustryDrug Manufacturers - General
ISINFI0009014377
Valuation
P/E (Trailing)19.14
P/E (Forward)15.60
PEG5.73
EV/EBITDA14.24
EV/Revenue5.26
P/S5.19
P/B9.03
EPS (TTM)3.76
EPS (Forward)4.61
52W Range
56.5082% of range75.30
52W High75.30 EUR
52W Low56.50 EUR
Profitability
Gross Margin64.20%
Oper. Margin27.46%
EBITDA Margin36.91%
Profit Margin26.48%
ROE38.95%
ROA24.89%
Growth
Revenue Growth17.80%
Earnings Growth46.70%
Cash Flow & Leverage
Operating CF344.35M $
CapEx (TTM)106.09M $
FCF Margin16.81%
FCF Yield3.24%
Net Debt142.39M $
Net Debt/EBITDA0.18
Balance Sheet
Debt/Equity0.24
Current Ratio1.77
Quick Ratio1.13
Book Value/Sh7.968 EUR
Cash/Share1.415 EUR
Dividends
Fwd Div Rate1.800 EUR
Trail. Div Rate1.800 EUR
Div. Yield2.53%
5Y Avg Yield3.29%
Payout Ratio45.74%
Ex-Div DateOct 19, 2026
Pay Date
Analyst Consensus
Rating1.8 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)74.33 EUR
Upside (mean)+3.3%
Target Range55.00 EUR81.00 EUR
55.00+3.3% to mean81.00
# Analysts6
Ownership
Shares Out.109.34M
Float123.11M
Insiders2.64%
Institutions44.98%
Technical
SMA 5069.65 (+3.3%)
SMA 20067.11 (+7.2%)
Beta0.28
S&P 52W Chg20.05%
Avg Vol (30d)211.29K
Avg Vol (10d)158.56K
Technical Indicators
RSI (14)61.2
MACD0.1246
MACD Signal-0.2443
MACD Hist.+0.3688
BB Upper71.64 EUR
BB Middle68.99 EUR
BB Lower66.34 EUR
BB Width7.69%
ATR (14)1.668 EUR
Vol Ratio (20d)0.86x